News
100 days CEO of ELPRO ... Five Questions for Josef Schmid
Josef Schmid @ elproINTERVIEW: Challenges, opportunity and future direction of ELPRO
Get insights on safeguarding biologics and optimizing the blend of technology and best practices from an industry thought leader at ELPRO.
Temperature-sensitive biologics and therapies are expensive and often require an ultra-cold supply chain to ensure the products are safe and maintain their efficacy throughout the entire journey to patients. This informative article by Suzanne Shelley explores the highly complex nature of this supply chain and the challenges facing product packaging, temperature control and logistics professionals.
Industry experts from UPS Healthcare, Sonoco Thermosafe, ELPRO, Kuehne+Nagel, CSafe Global and others provide insights into technological advancements and best practices.
“When it comes to container designs, insulation, and PCM materials, monitoring, and control systems and versatile cloud-based solutions to enable greater visibility, stakeholders should keep up with ongoing advances and be willing to embrace best-in-class solutions, rather than becoming locked into a particular solution. The entire chain is only as strong as its weakest link,” says ELPRO’s Schäpper. 1
1 C. Spivey. Six Approaches Making the Most Significant Impact in the Future. BioPharm International 2023 36 (1)